These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 3938461

  • 1. [The clinical efficacy of antithrombin III concentrate in infections complicated by DIC].
    Kobayashi H, Kawai S, Oshitani H, Tamakuma S, Hayasaka H, Akiyama M, Nakamura T, Hashimoto I, Sawada Y, Takebe K.
    Kansenshogaku Zasshi; 1985 Nov; 59(11):1121-34. PubMed ID: 3938461
    [No Abstract] [Full Text] [Related]

  • 2. Is antithrombin III for sepsis-associated disseminated intravascular coagulation really ineffective?
    Iba T, Thachil J.
    Intensive Care Med; 2016 Jul; 42(7):1193-4. PubMed ID: 27143022
    [No Abstract] [Full Text] [Related]

  • 3. Antithrombin III and sepsis.
    Mammen EF.
    Intensive Care Med; 1998 Jul; 24(7):649-50. PubMed ID: 9722032
    [No Abstract] [Full Text] [Related]

  • 4. Disseminated intravascular coagulation with multiple arterial thromboses responding to antithrombin-III concentrate infusion.
    Wisecarver JL, Haire WD.
    Thromb Res; 1989 Jun 15; 54(6):709-17. PubMed ID: 2781511
    [Abstract] [Full Text] [Related]

  • 5. Therapeutic use of antithrombin concentrate in sepsis.
    Balk R, Emerson T, Fourrier F, Kruse JA, Mammen EF, Schuster HP, Vinazzer H.
    Semin Thromb Hemost; 1998 Jun 15; 24(2):183-94. PubMed ID: 9579641
    [Abstract] [Full Text] [Related]

  • 6. Anticoagulant therapy by continuous heparin-antithrombin III infusion in newborns with disseminated intravascular coagulation.
    von Kries R, Stannigel H, Göbel U.
    Eur J Pediatr; 1985 Jul 15; 144(2):191-4. PubMed ID: 4043133
    [Abstract] [Full Text] [Related]

  • 7. Therapeutic modalities to ameliorate endotoxin induced DIC in the rats.
    Bahrami S, Paul E, Redl H, Schlag G.
    Prog Clin Biol Res; 1989 Jul 15; 308():977-82. PubMed ID: 2780743
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Antithrombin III in intensive therapy].
    Baudo F, Caimi TM, Decataldo F, Calori G.
    Minerva Anestesiol; 1999 Jul 15; 65(1-2 Suppl 1):71-6. PubMed ID: 10206028
    [No Abstract] [Full Text] [Related]

  • 17. Coagulation inhibitors in sepsis and disseminated intravascular coagulation.
    Lee WL, Downey GP.
    Intensive Care Med; 2000 Nov 15; 26(11):1701-6. PubMed ID: 11193281
    [Abstract] [Full Text] [Related]

  • 18. [Fundamental studies on the management of disseminated intravascular coagulation (DIC) with antithrombin III (AT-III) concentrate].
    Gotoh K.
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Apr 15; 37(4):571-80. PubMed ID: 3989338
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Antithrombin III supplementation in severe sepsis: beneficial effects on organ dysfunction.
    Inthorn D, Hoffmann JN, Hartl WH, Mühlbayer D, Jochum M.
    Shock; 1997 Nov 15; 8(5):328-34. PubMed ID: 9361342
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.